Atlas Trials

Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy

Clinical trial NCT03542006 · UNKNOWN

Trial details

NCT number
NCT03542006
Sponsor
Tel-Aviv Sourasky Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Central Serous Chorioretinopathy
Start date
2018-06-01
Primary completion
2019-01-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.